Advancement in HCC imaging: Diagnosis, staging and treatment efficacy assessments. Imaging diagnosis and staging of hepatocellular carcinoma

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 17, Issue 4, 2010, Pages 369-373

  Choi, Byung Ihn ^a   Lee, Jeong Min ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

CT MRI; Diagnosis; Hepatocellular carcinoma; Imaging; Staging; Ultrasound

Indexed keywords

GADOBENIC ACID; GADOLINIUM; SUPERPARAMAGNETIC IRON OXIDE;

CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; ELASTOGRAPHY; HEPATOGRAPHY; HUMAN; LIVER CELL CARCINOMA; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; DIFFERENTIAL DIAGNOSIS; LIVER TUMOR; METHODOLOGY; MULTIMODALITY CANCER THERAPY; REPRODUCIBILITY;

CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; LIVER NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 79952108531     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-009-0227-y     Document Type: Review

References (34)

1. Bruix J, Sherman M, Management of Hepatocellular Carcinoma. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Hepatology. 2005;42:1208-36. (Pubitemid 43112690)
2. Marrero JA. Screening tests for hepatocellular carcinoma. Clin Liver Dis. 2005;9:235-51.
3. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008;134:1752-63. (Pubitemid 351615415)
4. Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology. 2008;247:311-30.
5. Choi BI. The current status of imaging diagnosis of hepatocellular carcinoma. Liver Transpl. 2004;10:S20-5.
6. Miller G, Schwartz LH, D'Angelica M. The use of imaging in the diagnosis and staging of hepatobiliary malignancies. Surg Oncol Clin N Am. 2007;16:343-68. (Pubitemid 46874225)
7. Colli A, Fraquelli M, Casazza G, et al. Accuracy of ultrasonography, spiral CT, magnetic resonance and alph-fetoprotein in diagnosing hepatocellular carcinoma: a systemic review. Am J Gastroenterol. 2006;101:513-23. (Pubitemid 43340927)
8. Tanaka S, Kitamra T, Fujita M, Kasugai H, Inoue A, Ishiguro S. Small hepatocellular carcinoma: differentiation from adenomatous hyperplastic nodule with color Doppler flow imaging. Radiology. 1992;182:161-5.
9. Wilson SR, Burns PN. An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography. AJR. 2006;186:1401-12. (Pubitemid 46115735)
10. Hatanaka K, Kudo M, Minami Y, et al. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology. 2008;51(Suppl 1):61-9.
11. Fahey BJ, Nelson RC, Bradway DP, Hsu SJ, Dumont DM, Trahey GE. In vivo visualization of abdominal malignancies with acoustic radiation force elastography. Phys Med Biol. 2008;53:279-93.
12. Zech CJ, Reiser MF, Herrmann KA. Imaging of hepatocellular carcinoma by computed tomography and magnetic resonance imaging: state of the art. Dig Dis. 2009;27:114-24.
13. Lencioni R, Cioni D, Pina CD, Crocetti L, Bartolozzi C. Hepatocellular carcinoma: imaging diagnosis. Seminar Liver Disease. 2005;25:162-70.
14. Iannaccone R, Laghi A, Catalano C, et al. Hepatocellular carcinoma: role of unenhanced and delayed-phase multi-detector row helical CT in patients with cirrhosis. Radiology. 2005;234:460-7. (Pubitemid 40139917)
15. Kim SH, Choi BI, Lee JY, et al. Diagnostic accuracy of multi-/ single-detector row CTand contrast-enhanced MRI in the detection of hepatocellular carcinomas meeting the Milan Criteria before liver transplantation. Intervirology. 2008;51(Suppl 1):52-60. (Pubitemid 351821843)
16. Ariff B, Lloyd CR, Khan S, et al. Imaging of liver cancer. World J Gastroenterol. 2009;15:1289-300.
17. Brancatelli G, Baron RL, Peterson MS, Marsh W. Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation. AJR Am J Roentgenol. 2003;180:1007-14. (Pubitemid 36363042)
18. Sahani DV, Holalkere NS, Mueller PR, Zhu AX. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue-initial experience. Radiology. 2007;243:736-43. (Pubitemid 46799427)
19. Zhu AX, Holalkere NS, Muzikansky A, Horgan K, Sahani DV. Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma. Oncology. 2008;13:120-5. (Pubitemid 351342575)
20. Marrero JA, Hussain HK, Nghiem HV, et al. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterial enhancing liver mass. Liver Transpl. 2005;11:281-9. (Pubitemid 40458400)
21. Kim YK, Kim CS, Chung GH, et al. Comparison of gadobenate dimeglumine-enhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma. AJR. 2006;186:149-57.
22. Ebara M, Ohto M, Watanabe Y, et al. Diagnosis of small hepatocellular carcinoma: correlation of MR imaging and tumor histologic studies. Radiology. 1986;159:371-7.
23. Kim YK, Kim CS, Kwak HS, Lee JM. Three dimensional dynamic liver MRI imaging using sensitivity encoding for detection of hepatocellular carcinomas; comparison with super-paramagnetic rion oxide-enhanced MR imaging. J Magn Reson Imaging. 2004;20:826-37. (Pubitemid 39426079)
24. Youk JH, Lee JM, Kim CS. MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents. AJR Am J Roentgenol. 2004;183:1049-54. (Pubitemid 44185095)
25. Yoo HJ, Lee JM, Lee MW, et al. Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, high-resolution 3.0T-MR imaging with pathologic correlation. Invest Radiol. 2008;43:538-46.
26. Kim JI, Lee JM, Choi JY, et al. The value of gadobenate dimeglumine-enhanced delayed-phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver. Invest Radiol. 2008;43:202-10. (Pubitemid 351643147)
27. Marin D, Di Martino M, Guerrisi A, De Filippis G, Rossi M, Ginanni Corradini S, et al. Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT. Radiology. 2009;251:85-95.
28. Kim SH, Kim SH, Lee J, et al. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR. 2009;192:1675-81.
29. Bartolozzi C, Crocetti L, Lencioni R, et al. Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol. 2007;17:2519-30.
30. Greene FL, Page DL, Fleming ID, Firtz A, Balch CM, Haller DG, Morrow M. AJCC cancer staging manual. 6th ed. Chicago: Springer; 2002. 435 p.
31. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer. 1985;56:918-28. (Pubitemid 15228292)
32. The cancer of the liver italian program (CLIP) investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology. 1998;28:751-5.
33. Marrero JA, Fontana RJ, Barrat A, et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology. 2005;41:707-16.
34. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-9. (Pubitemid 26079803)